Poclight Biotechnology
Suzhou, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A developer of rapid point-of-care diagnostic devices and tests for clinical and potentially home use.
Infectious Disease
Technology Platform
Develops integrated point-of-care diagnostic systems combining microfluidics, assay chemistry, and portable optical readers.
Opportunities
The global trend toward decentralized and rapid testing, accelerated by the COVID-19 pandemic, drives demand for POC solutions.
Risk Factors
Faces intense price competition, rapid technological obsolescence, and stringent regulatory requirements for market approval.
Competitive Landscape
Competes with a wide range of global POC leaders like Abbott and Roche, as well as many cost-focused Chinese manufacturers.